Home › Attention Deficit Hyperactivity Disorder › NCT06971640

Advancing Identification of Circadian Delay in ADHD Youth: Associations With Clinical Heterogeneity and Cognition

Who can join

Ages 6 to 9 · All sexes

Inclusion Criteria:

1. Child ages 6-9
2. Meet criteria for a primary psychiatric diagnosis of DSM-5 ADHD, any presentation
3. Intellectual functioning \>80
4. Healthy (i.e., no major medical problems)
5. If applicable, willingness to suspend use of melatonin during the study period

Exclusion Criteria:

1. Meet DSM-5 criteria for psychosis, bipolar, or autism spectrum disorders
2. Diagnosis of occult sleep disorders, including sleep apnea or restless leg syndrome
3. Medication for sleep other than melatonin
4. Plans to initiate stimulant medication during the study period

About the study

The purpose of this study is to better understand sleep and circadian functioning in children with ADHD using home-based measures, parent report, and a lab based melatonin assessment. Investigators will also examine how sleep relates to psychiatric health and cognition among children with ADHD. The investigator for this study is Dr. Jessica Lunsford-Avery from the Department of Psychiatry.

Sponsor: Duke University · Participants: 250 · Started: May 28, 2025

Contact the study team

• Matt Gibson · Phone: 919-681-2521

Official record on ClinicalTrials.gov — NCT06971640

Locations in the U.S.

Conditions

• Attention Deficit Hyperactivity Disorder

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.